We present a case of an aneurysm of Galen vein in an infant with concomitant large hydrocephalus, treated by ventriculoperitoneal shunting and combined transtorcular-transfemoral embolization with a good clinical outcome. The technical aspect of the procedure is described in detail; current concepts concerning the pathophysiology and data in the available literature are reviewed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

case galen's
4
galen's vein
4
vein aneurysm
4
aneurysm infant
4
infant treated
4
treated combined
4
combined transtorcular/transfemoral
4
transtorcular/transfemoral embolization]
4
embolization] case
4
case aneurysm
4

Similar Publications

Evaluation of adherence to the Preferred Reporting of CasE Series in Surgery (PROCESS) 2020 guideline in case series describing endovascular management of vein of Galen malformation demonstrates suboptimal reporting practices.

J Clin Neurosci

January 2025

Department of Medical Imaging, Children's Hospital at Westmead, Westmead, Australia; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Background: Interventional neuroradiology is a dynamic field with technological advancements constantly driving evolution in clinical practice. Case series provide interventional neuroradiologists the opportunity to describe the clinical implications of novel equipment and techniques almost in real-time, informing broader adoption and directing future research. Complete reporting in case series is vital in enabling readers to detect bias, determine the generalizability of results and replicate study methodology.

View Article and Find Full Text PDF

Objective: There is a lack of consensus regarding the optimal antithrombotic therapy (ATT) after popliteal and infrapopliteal (PIP) endovascular therapy (EVT). Currently, dual antiplatelet therapy (DAPT) for 3 months and single antiplatelet therapy (SAPT) are the most prescribed regimens in the Netherlands. Thus far, no randomized comparison has been performed on the optimal ATT approach.

View Article and Find Full Text PDF

Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that usually manifests before 18 months of age and is characterized by recurrent, alternating episodes of hemiparesis with variable frequency and can last from a few minutes to several days. We present a case of AHC in a little girl carrying a sporadic mutation in the ATP1A3 gene (p.Glu815Lys) refractory to flunarizine and non-compliant to topiramate due to adverse effects treated with oral compound of adenosine-5'-triphosphate (ATP) capsules.

View Article and Find Full Text PDF

Protocol for mitochondrial variant enrichment from single-cell RNA sequencing using MAESTER.

STAR Protoc

January 2025

Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA. Electronic address:

Single-cell RNA sequencing (scRNA-seq) enables detailed characterization of cell states but often lacks insights into tissue clonal structures. Here, we present a protocol to probe cell states and clonal information simultaneously by enriching mitochondrial DNA (mtDNA) variants from 3'-barcoded full-length cDNA. We describe steps for input library preparation, mtDNA enrichment, PCR product cleanup, and paired-end sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • Two cases of vein of Galen aneurysmal malformation were identified in early life, showing different outcomes.
  • The findings indicate that early detection does not always lead to a bad prognosis.
  • This emphasizes the importance of careful monitoring and prompt treatment to improve patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!